Without the ability to produce vaccines onshore, Australia and the region remain vulnerable to supply shocks and ‘vaccine nationalism’, the Academy of Science says in a pre-budget submission to...
Australia’s largest company by market capitalisation, biotechnology manufacturer CSL has powered ahead in the first half of the financial year reporting a net profit after tax up 44 per...
“If plan A doesn’t work, the alphabet has 25 more letters – 46 if you’re in Japan.” (Claire Cook, Seven Year Switch) In the late 1980s and early 1990s...
Biotechnology giant CSL will spend more than $800 million building a new vaccine manufacturing plant at the Melbourne Airport Business Park, with operations expected to start in 2026. The...
The federal government has put out a nationwide call to local manufacturers seeking information as part of preparation to produce future vaccines and treatments for COVID-19 at scale. The...
Newsletter Signup
Subscribe to our newsletter for InnovationAus news delivered right to your inbox.